Skip to main content

Advertisement

Log in

Parasites of the small intestine

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

This paper discusses the most important parasites that inhabit the human small intestine. Beginning with the protozoa and proceeding through the various species of cestodes, nematodes, and trematodes that inhabit the human small bowel, the most important organisms are presented. Possible future developments are discussed along with pathophysiology and treatment in this phylogenic approach. Zoonotic illnesses, those diseases that by their rarity are of little import, and diseases without significant clinical or social implications are beyond the scope of this article and are not discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

References and Recommended Reading

  1. Hanson KL, Cartwright CP: Use of an enzyme immunoassay does not eliminate the need to analyze multiple stool specimens for sensitive detection of Giardia lamblia. J Clin Microbiol 2001, 39:474–477.

    Article  PubMed  CAS  Google Scholar 

  2. Centers for Disease Control and Prevention: Cryptosporidiosis Surveillance — United States 1999–2002 and Giardiasis Surveillance — United States, 1998–2002. In Surveillance Summaries, January 28,2005. MMWR 2005:54(No. SS-1). This is a valuable overview of the impact, transmission, and control of these two important parasitic illnesses. Its value is underscored by its timeliness and relevance to a broad spectrum of medical practices.

  3. Thompson RC: Giardiasis as a re-emerging infectious disease and its zoonotic potential. Int J Parasitol 2000, 30:1259–1267.

    Article  PubMed  CAS  Google Scholar 

  4. Kappus KD, Lundgren RG, Juranek, DD, et al.: Intestinal parasitism in the United States: update on a continuing problem. Am J Trop Med Hyg 1994, 50:705–713.

    PubMed  CAS  Google Scholar 

  5. Aldeen WE, Carroll K, Robison A, et al.: Comparison of nine commercially available enzyme-linked immunosorbent assays for detection of Giardia lamblia in fecal specimens. J Clin Microbiol. 1998, 36:1338–1340.

    PubMed  CAS  Google Scholar 

  6. Bingham AK, Meyer EA: Giardia excystation can be induced in vitro in acidic solutions. Nature 1979, 277:301–302.

    Article  PubMed  CAS  Google Scholar 

  7. Boucher SEM, Gillin FD: Excystation of in vitro-derived Giardia lamblia cysts. Infect Immun 1990, 58:3516–3522.

    PubMed  CAS  Google Scholar 

  8. Mastropasqua E, Rolandi R, Farruggio A, Lirussi F: Giardia duodenalis: a confounding factor for the diagnosis of celiac disease. J Clin Gastroenterol 2003, 36:185–186.

    Article  PubMed  Google Scholar 

  9. Hartong WA, Gourley WK, Arvanitakis C: Giardiasis: clinical spectrum and functional-structural abnormalities of the small intestinal mucosa. Gastroenterology 1979, 77:61–69.

    PubMed  CAS  Google Scholar 

  10. Farthing MJ. The molecular pathogenesis of giardiasis. J Pediatr Gastroenterol Nutr 1997, 24:79–88.

    Article  PubMed  CAS  Google Scholar 

  11. Rossignol JA, Ayoub A, Ayers MS: Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis 2001, 184:103–106.

    Article  PubMed  CAS  Google Scholar 

  12. Roy SL, DeLong SM, Stenzel SA, et al.: Emerging Infections Program FoodNet Working Group. Risk factors for sporadic cryptosporidiosis among immunocompetent persons in the United States from 1999 to 2001. J Clin Microbiol 2004, 42:2944–2951.

    Article  PubMed  Google Scholar 

  13. Colford JM Jr, Tager IB, Hirozawa AM, et al.: Cryptosporidiosis among patients infected with human immunodeficiency virus. Factors related to symptomatic infection and survival. Am J Epidemiol 1996, 144:807–816.

    PubMed  Google Scholar 

  14. Goldin RD, Hunt J: Biliary tract pathology in patients with AIDS. J Clin Pathol 1993, 46(8):691–693.

    PubMed  CAS  Google Scholar 

  15. Tumwine JK, Kekitiinwa A, Nabukeera N, et al.: Cryptosporidium parvum in children with diarrhea in Mulago Hospital, Kampala, Uganda. Am J Trop Med Hyg 2003, 68(6):710–715.

    PubMed  Google Scholar 

  16. Smerdon WJ, Nichols T, Chalmers RM, et al.: Foot and mouth disease in livestock and reduced cryptosporidiosis in humans, England and Wales. Emerg Infect Dis 2003, 9:22–28.

    PubMed  Google Scholar 

  17. Chen XM, Keithly JS, Paya CV, LaRusso NF: Cryptosporidiosis. N Engl J Med 2002, 346:1723–1731.

    Article  PubMed  Google Scholar 

  18. Mehta P: Laboratory diagnosis of cryptosporidiosis. J Postgrad Med 2002, 48:217–221.

    PubMed  CAS  Google Scholar 

  19. Rossignol JF, Ayoub A, Ayers MS: Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis 2001, 184:103–106.

    Article  PubMed  CAS  Google Scholar 

  20. Miao YM, Awad-El-Kariem FM, Franzen C, et al.: Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy. J Acquir Immune Defic Syndr 2000, 25:124–129.

    Article  PubMed  CAS  Google Scholar 

  21. Ramos JT, Saavedra J, Ruiz-Contreras J: Cryptosporidium in patients infected with human immunodeficiency virus: azithromycin revisited. J Pediatr 1997, 130:1009–1010.

    Article  PubMed  CAS  Google Scholar 

  22. Dionisio D, Orsi A, Sterrantino G, et al.: Chronic cryptosporidiosis in patients with AIDS: stable remission and possible eradication after long-term, low dose azithromycin. J Clin Pathol 1998, 51:138–142.

    PubMed  CAS  Google Scholar 

  23. Centers for Disease Control and Prevention: Recommendations of the International Task Force for Disease Eradication. MMWR 1993, 42(No. RR-16) This reference provides valuable insight into global population medicine. It includes summaries of all six diseases slated for eradication and also several others that may be future targets for eradication.

  24. Garcia HH, Gilman RH, Gonzalez AE, et al.: Cysticercosis Working Group in Peru. Hyperendemic human and porcine Taenia solium infection in Peru. Am J Trop Med Hyg 2003, 68:268–275.

    PubMed  Google Scholar 

  25. Vazquez-Flores S, Ballesteros-Rodea G, Flisser A, Schantz PM: Hygiene and restraint of pigs is associated with absence of Taenia solium cysticercosis in a rural community of Mexico. Salud Publica Mex 2001, 43:574–576.

    PubMed  CAS  Google Scholar 

  26. Carpio A, Hauser WA: Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2002, 59:1730–1734.

    PubMed  Google Scholar 

  27. Bragazza LM, Vaz AJ, Passos AD, et al.: Frequency of serum anti-cysticercus antibodies in the population of a rural Brazilian community (Cassia dos coqueiros, SP) determined by ELISA and immunoblotting using Taenia crassiceps antigens. Rev Inst Med Trop Sao Paulo 2002, 44:7–12.

    PubMed  Google Scholar 

  28. Garcia HH, Gonzalez AE, Gilman RH, et al.: Cysticercosis Working Group in Peru. Short report: transient antibody response in Taenia solium infection in field conditions-a major contributor to high seroprevalence. Am J Trop Med Hyg 2001, 65:31–32.

    PubMed  CAS  Google Scholar 

  29. DeGiorgio C, Pietsch-Escueta S, Tsang V, et al.: Seroprevalence of Taenia solium cysticercosis and Taenia solium taeniasis in California, USA. Acta Neurol Scand 2005, 111:84–88.

    Article  PubMed  CAS  Google Scholar 

  30. Proano-Narvaez JV, Meza-Lucas A, Mata-Ruiz O, et al.: Laboratory diagnosis of human neurocysticercosis: doubleblind comparison of enzyme-linked immunosorbent assay and electroimmunotransfer blot assay. J Clin Microbiol 2002, 40:2115–2118.

    Article  PubMed  CAS  Google Scholar 

  31. Suss RA, Maravilla KR, Thompson J: MR imaging of intracranial cysticercosis: comparison with CT and anatomopathologic features. Am J Neuroradiol 1986, 7:235–242.

    PubMed  CAS  Google Scholar 

  32. Mehta SS, Hatfield S, Jessen L, Vogel D: Albendazole versus praziquantel for neurocysticercosis. Am J Health Syst Pharm 1998, 55:598–600.

    PubMed  CAS  Google Scholar 

  33. Garcia HH, Gilman RH, Horton J, et al.: Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. Neurology 1997, 48:1421–1427.

    PubMed  CAS  Google Scholar 

  34. Hachinski V: Medical treatment of cysticercosis. Arch Neurol 1995, 52:104.

    PubMed  CAS  Google Scholar 

  35. del Brutto OH: Medical treatment of cysticercosis—effective. Arch Neurol 1995, 52:102–104.

    PubMed  Google Scholar 

  36. Kramer LD: Medical treatment of cysticercosis—ineffective. Arch Neurol 1995, 52:101–102.

    PubMed  CAS  Google Scholar 

  37. von Bonsdorff B, Gordin R: Castle’s test (with vitamin B12 and normal gastric juice) in the ileum in patients with genuine and patients with tapeworm pernicious anaemia. Acta Med Scand 1980, 208:193–197.

    Article  Google Scholar 

  38. Khuroo MS: Asciriasis. Gastroenterol Clin North Am 1996, 25:553–577.

    Article  PubMed  CAS  Google Scholar 

  39. Seltzer, E. Ascariasis. In Tropical Infectious Diseases: Principles, Pathogens and Practice, edn 1. Edited by Guerrant RL, Weller PF. Philadelphia: Churchill Livingstone; 1999:553–577.

    Google Scholar 

  40. Mahmoud AAF: Intestinal nematodes (roundworms). In Principles and Practice of Infectious Diseases, edn 5. Edited by Mandell GL, Douglas RG, Benett JE. New York: Churchhill Livingstone; 2000:2938–2943.

    Google Scholar 

  41. Chu, WG, Chen PM, Huag CC et al.: Neonatal ascariasis. J Pedriatr 1972, 81:783–785.

    Article  CAS  Google Scholar 

  42. Lindo JF, Dubon JM, Ager AL, et al.: Intestinal parasitic infections in human immunodeficiency virus (HIV)-positive and HIV-negative individuals in San Pedro Sula, Honduras. Am J Trop Med Hyg 1998, 58:431–435.

    PubMed  CAS  Google Scholar 

  43. Swartzman J: Ascariasis. In Hunter’s Tropical Medicine and Emerging Infectious Disease, edn 8. Edited by Strickland GT. Philadelphia: WB Saunders Co.; 2000:726–729.

    Google Scholar 

  44. Oberhelmon RA, Guerrero ES, Fernandez ML, et al.: Correlation between intestinal parasitosis, physical growth, and psychomotor development among infants and children from rural Nicaragua. Am J Trop Med Hyg 1998, 58:470–475.

    Google Scholar 

  45. Hlaing T: Ascariasis and childhood malnutrition. Parasitology 1993, 107(Suppl):S125-S136.

    Article  PubMed  Google Scholar 

  46. Hall A: Intestinal parasitic worms and the growth of children. Trans R Soc Trop Med Hyg 1993, 87:241–242.

    Article  PubMed  CAS  Google Scholar 

  47. Weller, PF: Parasitic pneumonias. In Respiratory Infections: Diagnosis and Management, edn 3. Edited by Pennington JE. New York: Raven Press; 1994:695.

    Google Scholar 

  48. Shad JA, Lee YR: Pancreatits due to Ascaris lumbricoides: second occurance after 2 years. South Med J 2001, 94(1):78–80.

    PubMed  CAS  Google Scholar 

  49. Hall A, Anwar KS, Tomkins AM: Intensity of reinfection with Ascaris lumbricoides and its implications for parasite control. Lancet 1992, 339:1253–1257.

    Article  PubMed  CAS  Google Scholar 

  50. Igra-Siegman Y, Kapila R, Sen P, et al.: Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis 1981, 3:397–407.

    PubMed  CAS  Google Scholar 

  51. Beal CB, Viens P, Grant RG, Hughes JM: A new technique for sampling duodenal contents. Demonstration of upper smallbowel pathogens. Am J Trop Med Hyg 1970, 19:349–252.

    PubMed  CAS  Google Scholar 

  52. Savage D, Foadi M, Haworth C, Grant A: Marked eosinophiliain an immunosuppresed patient with strongyloidiasis. J Intern Med 1994, 236:473–475.

    Article  PubMed  CAS  Google Scholar 

  53. Kalg RE, Grossman ME: Periumbilical purpura in disseminated strongyloidiasis. JAMA 1986, 256:1170–1171.

    Article  Google Scholar 

  54. Scowden EB, Schaffner W, Stone WJ: Overwhelming strongyloidiasis: an unappreciated opportunistic infection. Medicine (Baltimore) 1978, 57:527–544.

    CAS  Google Scholar 

  55. Genta RM: Global prevalence of strongyloides: critical review with epidemiological insights into the prevention of disseminated disease. Rev Infect Dis 1989, 11:755–767.

    PubMed  CAS  Google Scholar 

  56. Linder JD, Monkemuller KE, Lazenby AJ, Wilcox CM: Streptococcus bovis bacteremia associated with Strongyloides stercoralis colitis. Gasrointest Endosc 2000, 52:796–798.

    Article  CAS  Google Scholar 

  57. Lee MG, Terry SI: Arteriomesenteric duodenal occlusion associated with strongyloidiasis. J Trop Med Hyg 1989, 92:41–45.

    PubMed  CAS  Google Scholar 

  58. Sato Y, Kobayashi J, Toma H, Shiroma Y: Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg 1995, 539:248–250.

    Google Scholar 

  59. Maxwell C, Hussain R, Nutman TB, et al.: The clinical and immunologic responses of normal human volunteers to low dose hookworm (Necator americanus) infection. Am J Trop Med Hyg 1987, 37:126–134.

    PubMed  CAS  Google Scholar 

  60. Hotez PJ, Pritchard DI: Hookworm infection. Sci Am 1995, 272:68–74.

    PubMed  CAS  Google Scholar 

  61. Stanssens P, Bergum PW, Gansemans Y, et al.: Anticoagulant repertoire of the hookworm Ancylostoma caninum. Proc Natl Acad Sci USA 1996, 93:2149–2154.

    Article  CAS  Google Scholar 

  62. Anyaeze CM: Reducing burden of hookworm disease in the management of upper abdominal pain in the tropics. Trop Doct 2003, 33:174–175.

    PubMed  Google Scholar 

  63. de Silva, NR, Brooker, S, Hotez, PJ, et al.: Soil-transmitted helminth infections: updating the global picture. Trends Parasitol 2003, 19:547–551.

    Article  PubMed  Google Scholar 

  64. Kato T, Kamoi R, Iida M, et al.: Endoscopic diagnosis of hookworm disease of the duodenum. J Clin Gastroenterol 1997, 24:100–102.

    Article  PubMed  CAS  Google Scholar 

  65. Stephenson LS, Latham MC, Kurz KM, et al.: Treatment with a single dose of albendazole improves growth of Kenyan schoolchildren with hookworm, Trichuris trichiura, and Ascaris lumbricoides infection. Am J Trop Med Hyg 1989, 41:78–87.

    PubMed  CAS  Google Scholar 

  66. Sakti H, Nokes C, Hertanto WS, et al.: Evidence for an association between hookworm infection and cognitive function in Indonesian school children. Trop Med Int Health 1999, 4:322–334.

    Article  PubMed  CAS  Google Scholar 

  67. Bethony J, Chen J, Lin S, et al.: Emerging patterns of hookworm infection: influence of aging on the intensity of Necator infection in Hainan Province, People’s Republic of China. Clin Infect Dis 2002, 35:1336–1344.

    Article  PubMed  Google Scholar 

  68. Olatunde BO, Onyemelukwe GC, et al.: Immunosuppression in Nigerians with hookworm infection. Afr J Med Sci 1994, 23:221–225.

    CAS  Google Scholar 

  69. Loukas A, Prociv P: Immune responses in hookworm infections. Clin Microbiol Rev 2001, 14:689–703. The authors provide an interesting insight into future directions for reducing the toll of hookworm infection throughout the world.

    Article  PubMed  CAS  Google Scholar 

  70. Brooker S, Bethony J, Hotez PJ: Human hookworm infection in the 21st century. Adv Parasitol 2004, 58:197–288.

    Article  PubMed  Google Scholar 

  71. Fincham JE, Markus MB, Adams VJ: Could control of soiltransmitted heminthic infection influence the HIV/AIDS pandemic? Acta Trop 2003, 86:315–333.

    Article  PubMed  Google Scholar 

  72. Nacher M, Singhasivanon P, Yimsamran S, et al.: Intestinal helminth infections are associated with increased incidence of Plasmodium falciparum malaria in Thailand. J Parasitol 2002, 88:55–58.

    PubMed  CAS  Google Scholar 

  73. Shapiro AE, Tukahebwa EM, Kasten J, et al.: Epidemiology of helminth infections and their relationship to clinical malaria in southwest Uganda. Trans R Soc Trop Med Hyg 2005, 99:18–24.

    Article  PubMed  Google Scholar 

  74. Modjarrad K, Zulu I, Redden DT, et al.: Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults. J Infect Dis 2005, 192:1277–1283.

    Article  PubMed  CAS  Google Scholar 

  75. Prevention and control schistosomiasis and soil-transmitted helminthiasis. World Health Organ Tech Rep Ser 2002, 912:1–57.

  76. Sabine Vaccine Institute: Human hookworm vaccine initiative (HHVI). Available at: http://www.sabin.org/hookworm.htm. Accessed 2/26/05.

  77. Chai JY, Lee SH: Food-borne intestinal trematode infections in the Republic of Korea. Parasitol Int 2002, 51:129–154.

    Article  PubMed  Google Scholar 

  78. Liu, LX, Harinasuta, KT: Liver and intestinal flukes. Gastroenterol Clin North Am 1996, 25:627–636.

    Article  PubMed  CAS  Google Scholar 

  79. Belizario VY Jr, Bersabe MJ, deLeon WU, et al.: Intestinal heterophyidiasis: an emerging food-borne parasitic zoonosis in southern Philippines. Southeast Asian J Trop Med Public Health 2001, 32) (Suppl 2):36–42.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Theodore W. Schafer MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schafer, T.W., Skopic, A. Parasites of the small intestine. Curr Gastroenterol Rep 8, 312–320 (2006). https://doi.org/10.1007/s11894-006-0052-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-006-0052-2

Keywords